AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Mesa Laboratories Inc Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Mesa Laboratories, Inc. drew $97 million under its existing senior secured Credit Facility on August 12, 2025, bringing total outstanding borrowings under that facility to $108 million. The company used the proceeds to fund settlement of its outstanding convertible notes that matured on August 15, 2025, in accordance with the indenture.

The Credit Facility carries interest at either a base rate or a SOFR rate plus a spread and matures on April 5, 2029. The filing references the full credit agreement previously filed on April 8, 2024, and includes a press release as Exhibit 99.1 dated August 18, 2025.

Mesa Laboratories, Inc. ha preso in prestito 97 milioni di dollari nell'ambito della sua attuale Credit Facility senior garantita il 12 agosto 2025, portando l'indebitamento totale residuo sotto tale linea a 108 milioni di dollari. La società ha impiegato i proventi per estinguere i propri titoli convertibili in scadenza il 15 agosto 2025, conformemente all'atto costitutivo.

La Credit Facility prevede un tasso d'interesse basato su un tasso base oppure sul SOFR più uno spread e scade il 5 aprile 2029. Il deposito fa riferimento al contratto di credito completo precedentemente archiviato l'8 aprile 2024 e include un comunicato stampa in allegato come Exhibit 99.1 datato 18 agosto 2025.

Mesa Laboratories, Inc. obtuvo 97 millones de dólares de su actual línea de crédito garantizada senior el 12 de agosto de 2025, elevando el total de préstamos pendientes bajo esa facilidad a 108 millones de dólares. La compañía utilizó los fondos para liquidar sus pagarés convertibles vencidos el 15 de agosto de 2025, de conformidad con el contrato de emisión.

La línea de crédito aplica un interés basado en una tasa base o en SOFR más un margen y vence el 5 de abril de 2029. La presentación remite al acuerdo de crédito completo archivado el 8 de abril de 2024 e incluye un comunicado de prensa como Exhibit 99.1 con fecha 18 de agosto de 2025.

Mesa Laboratories, Inc.ëŠ� 2025ë…� 8ì›� 12ì� 기존ì� 선순ìœ� ë‹´ë³´ 신용한ë„ì—서 9,700ë§� 달러ë¥� ì¸ì¶œí•˜ì—¬ 해당 í•œë„ í•˜ì˜ ì´� 미ìƒí™� ì°¨ìž…ê¸ˆì´ 1ì–�8백만 달러가 ë˜ì—ˆìŠµë‹ˆë‹�. 회사ëŠ� ì� ìžê¸ˆì� 2025ë…� 8ì›� 15ì� 만기ë� 전환사채ì� ìƒí™˜ ìžê¸ˆìœ¼ë¡œ 사용했으ë©�, ì´ëŠ” ì¸ë´ì²˜ì— 따른 조치입니ë‹�.

해당 신용한ë„ëŠ� 기준금리 ë˜ëŠ” SOFRì—� 스프레드ë¥� ë”한 금리 ì¤� 하나ë¥� ì ìš©í•˜ë©° 만기ëŠ� 2029ë…� 4ì›� 5ì¼ìž…니다. 제출 서류ëŠ� 2024ë…� 4ì›� 8ì¼ì— 제출ë� ì „ì²´ 신용계약서를 참조하며, 2025ë…� 8ì›� 18ì¼ìž ë³´ë„ìžë£Œê°€ Exhibit 99.1ë¡� í¬í•¨ë˜ì–´ 있습니다.

Mesa Laboratories, Inc. a tiré 97 millions de dollars sur sa facilité de crédit senior garantie existante le 12 août 2025, portant le montant total des emprunts en cours sur cette facilité à 108 millions de dollars. La société a utilisé ces fonds pour solder ses billets convertibles arrivant à échéance le 15 août 2025, conformément à l'acte de fiducie.

La facilité de crédit porte un intérêt au taux de base ou au taux SOFR majoré d'une marge et arrive à échéance le 5 avril 2029. Le dépôt renvoie au contrat de crédit complet précédemment déposé le 8 avril 2024 et inclut un communiqué de presse en tant qu'Exhibit 99.1 daté du 18 août 2025.

Mesa Laboratories, Inc. zog am 12. August 2025 97 Millionen US-Dollar aus ihrer bestehenden besicherten Senior-Kreditfazilität und erhöhte damit die ausstehenden Gesamtkredite unter dieser Fazilität auf 108 Millionen US-Dollar. Das Unternehmen nutzte die Mittel zur Begleichung seiner am 15. August 2025 fälligen Wandelanleihen, entsprechend der Anleihebedingungen.

Die Kreditfazilität verlangt Zinsen entweder auf Basis eines Basiszinssatzes oder des SOFR zuzüglich eines Aufschlags und läuft am 5. April 2029 aus. Die Einreichung verweist auf den vollständigen Kreditvertrag, der zuvor am 8. April 2024 eingereicht wurde, und enthält eine Pressemitteilung als Exhibit 99.1 vom 18. August 2025.

Positive
  • Convertible notes settled using proceeds, eliminating the scheduled August 15, 2025 maturity under the indenture
  • Utilized existing credit facility rather than new financing, referencing an already-disclosed senior secured credit agreement
Negative
  • Outstanding debt increased to $108 million under the Credit Facility, raising secured leverage
  • Interest rate exposure tied to base rate or SOFR plus a spread introduces floating-rate cost risk

Insights

TL;DR: Company borrowed $97M to settle maturing convertible notes, raising outstanding debt to $108M under a credit facility maturing in 2029.

The draw converts near-term convertible note obligations into bank debt under the existing secured facility, eliminating the immediate note maturity event on August 15, 2025. This reduces potential near-term refinancing or conversion uncertainty tied to the notes but increases funded debt on the balance sheet to $108M under terms tied to base or SOFR rates plus a spread. Investors should note the credit facility maturity date of April 5, 2029, and that the filing incorporates the full credit agreement previously filed on April 8, 2024.

TL;DR: Settlement via credit draw removes convertible note maturity risk but increases interest rate exposure and secured leverage.

Replacing convertible notes with borrowings under a secured credit agreement reduces contingent equity dilution risk associated with convertible instruments but replaces it with higher secured leverage and floating-rate interest exposure (base rate or SOFR plus spread). The maturity profile now includes the facility's April 5, 2029 maturity. The filing is informational and references prior documentation for full terms.

Mesa Laboratories, Inc. ha preso in prestito 97 milioni di dollari nell'ambito della sua attuale Credit Facility senior garantita il 12 agosto 2025, portando l'indebitamento totale residuo sotto tale linea a 108 milioni di dollari. La società ha impiegato i proventi per estinguere i propri titoli convertibili in scadenza il 15 agosto 2025, conformemente all'atto costitutivo.

La Credit Facility prevede un tasso d'interesse basato su un tasso base oppure sul SOFR più uno spread e scade il 5 aprile 2029. Il deposito fa riferimento al contratto di credito completo precedentemente archiviato l'8 aprile 2024 e include un comunicato stampa in allegato come Exhibit 99.1 datato 18 agosto 2025.

Mesa Laboratories, Inc. obtuvo 97 millones de dólares de su actual línea de crédito garantizada senior el 12 de agosto de 2025, elevando el total de préstamos pendientes bajo esa facilidad a 108 millones de dólares. La compañía utilizó los fondos para liquidar sus pagarés convertibles vencidos el 15 de agosto de 2025, de conformidad con el contrato de emisión.

La línea de crédito aplica un interés basado en una tasa base o en SOFR más un margen y vence el 5 de abril de 2029. La presentación remite al acuerdo de crédito completo archivado el 8 de abril de 2024 e incluye un comunicado de prensa como Exhibit 99.1 con fecha 18 de agosto de 2025.

Mesa Laboratories, Inc.ëŠ� 2025ë…� 8ì›� 12ì� 기존ì� 선순ìœ� ë‹´ë³´ 신용한ë„ì—서 9,700ë§� 달러ë¥� ì¸ì¶œí•˜ì—¬ 해당 í•œë„ í•˜ì˜ ì´� 미ìƒí™� ì°¨ìž…ê¸ˆì´ 1ì–�8백만 달러가 ë˜ì—ˆìŠµë‹ˆë‹�. 회사ëŠ� ì� ìžê¸ˆì� 2025ë…� 8ì›� 15ì� 만기ë� 전환사채ì� ìƒí™˜ ìžê¸ˆìœ¼ë¡œ 사용했으ë©�, ì´ëŠ” ì¸ë´ì²˜ì— 따른 조치입니ë‹�.

해당 신용한ë„ëŠ� 기준금리 ë˜ëŠ” SOFRì—� 스프레드ë¥� ë”한 금리 ì¤� 하나ë¥� ì ìš©í•˜ë©° 만기ëŠ� 2029ë…� 4ì›� 5ì¼ìž…니다. 제출 서류ëŠ� 2024ë…� 4ì›� 8ì¼ì— 제출ë� ì „ì²´ 신용계약서를 참조하며, 2025ë…� 8ì›� 18ì¼ìž ë³´ë„ìžë£Œê°€ Exhibit 99.1ë¡� í¬í•¨ë˜ì–´ 있습니다.

Mesa Laboratories, Inc. a tiré 97 millions de dollars sur sa facilité de crédit senior garantie existante le 12 août 2025, portant le montant total des emprunts en cours sur cette facilité à 108 millions de dollars. La société a utilisé ces fonds pour solder ses billets convertibles arrivant à échéance le 15 août 2025, conformément à l'acte de fiducie.

La facilité de crédit porte un intérêt au taux de base ou au taux SOFR majoré d'une marge et arrive à échéance le 5 avril 2029. Le dépôt renvoie au contrat de crédit complet précédemment déposé le 8 avril 2024 et inclut un communiqué de presse en tant qu'Exhibit 99.1 daté du 18 août 2025.

Mesa Laboratories, Inc. zog am 12. August 2025 97 Millionen US-Dollar aus ihrer bestehenden besicherten Senior-Kreditfazilität und erhöhte damit die ausstehenden Gesamtkredite unter dieser Fazilität auf 108 Millionen US-Dollar. Das Unternehmen nutzte die Mittel zur Begleichung seiner am 15. August 2025 fälligen Wandelanleihen, entsprechend der Anleihebedingungen.

Die Kreditfazilität verlangt Zinsen entweder auf Basis eines Basiszinssatzes oder des SOFR zuzüglich eines Aufschlags und läuft am 5. April 2029 aus. Die Einreichung verweist auf den vollständigen Kreditvertrag, der zuvor am 8. April 2024 eingereicht wurde, und enthält eine Pressemitteilung als Exhibit 99.1 vom 18. August 2025.

false 0000724004 0000724004 2025-08-12 2025-08-12
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549   
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
Date of Report (Date of earliest event reported): August 12, 2025
 
 
 
MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
 
 
Colorado
(State or other jurisdiction of
incorporation)
0-11740
(Commission File Number)
84-0872291 (I.R.S. Employer
Identification No.)
 
12100 WEST SIXTH AVENUE,
LAKEWOODColorado
(Address of principal executive offices)
 
80228
(Zip Code)
 
Registrant’s telephone number, including area code: 303-987-8000
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered under Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol
 
Name of each exchange on which
registered
         
Common Stock, no par value
 
MLAB
 
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 
 
 

 
ITEM 2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.
 
On August 12, 2025, Mesa Laboratories, Inc. ("the "Company") drew $97 million under its existing Credit Facility. As of the date of this report, $108 million is outstanding under the Credit Facility.
 
The proceeds from the draw were used to fund the settlement of the Company's outstanding convertible notes that matured on August 15, 2025 in accordance with the terms of the indenture governing the notes.
 
The Credit Facility bears interest at either a base rate or a SOFR rate, plus an applicable spread. The Credit Facility matures on April 5, 2029.
 
The description of the Credit Facility in this Item 2.03 is qualified entirely by reference to the full text of the senior secured credit agreement, a copy of which was filed with the Company's Current Report on Form 8-K filed on April 8, 2024 and is incorporated by reference herein.
 
ITEM 9.01   Financial Statements and Exhibits
 
(d)
Exhibits
 
99.1
Press Release Dated August 18, 2025.
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
DATE: August 18, 2025
 
Mesa Laboratories, Inc.
   
(Registrant)
     
     
 
BY: 
/s/ Gary M. Owens  
   
Gary M. Owens
   
President and Chief Executive Officer
 
 
 

FAQ

What did Mesa Laboratories (MLAB) do on August 12, 2025?

Mesa drew $97 million under its existing Credit Facility on August 12, 2025, to fund settlement of its convertible notes.

How much is outstanding under Mesa's Credit Facility after the draw?

$108 million was outstanding under the Credit Facility as of the date of the report.

What were the proceeds used for?

Proceeds were used to fund the settlement of the company's outstanding convertible notes that matured on August 15, 2025.

What interest terms apply to the Credit Facility?

The Credit Facility bears interest at either a base rate or a SOFR rate plus an applicable spread.

When does the Credit Facility mature?

The Credit Facility matures on April 5, 2029.

Where can I find the full terms of the Credit Facility?

The filing references the senior secured credit agreement previously filed with the company's Current Report on April 8, 2024, which is incorporated by reference.
Mesa Laboratories

NASDAQ:MLAB

MLAB Rankings

MLAB Latest News

MLAB Latest SEC Filings

MLAB Stock Data

378.89M
5.22M
5.12%
95.72%
4.6%
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
United States
LAKEWOOD